Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol effects on nicotine administration
NCT00000297Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Oct 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of labetalol in Tobacco Use Disorder (TUD), sponsored by National Institute on Drug Abuse. Primary endpoints: Subjective measures and Physiological measures. Started Oct 1998; status: completed.
02
Drugs
labetalol
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00000297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000297.